FDA — authorised 21 July 2023
- Application: NDA212905
- Marketing authorisation holder: VERRICA PHARMS
- Local brand name: YCANTH
- Indication: SOLUTION — TOPICAL
- Status: approved
🇺🇸 Ycanth in United States
FDA authorised Ycanth on 21 July 2023
Marketing authorisation
Ycanth in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Ycanth approved in United States?
Yes. FDA authorised it on 21 July 2023.
Who is the marketing authorisation holder for Ycanth in United States?
VERRICA PHARMS holds the US marketing authorisation.